Denali Therapeutics Stock Target Price and Analyst Consensus

DNLI Stock  USD 24.69  0.47  1.94%   
The current analyst and expert consensus on Denali Therapeutics is Strong Buy, with 10 strong buy opinions. The current projected Denali Therapeutics target price consensus is 55.60 with 17 analyst opinions. Check out Macroaxis Advice on Denali Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For more detail on how to invest in Denali Stock please use our How to Invest in Denali Therapeutics guide.
The most common way Denali Therapeutics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Denali Therapeutics executives and customers to further validate their buy or sell advice. Denali Therapeutics buy-or-sell recommendation module provides average expert sentiment on the projected Denali Therapeutics target price to derive its highest and lowest estimates based on projected price volatility of 3.4226.
Lowest Forecast
50.6
Highest Forecast
61.72
Target Price
55.6
The Denali Therapeutics' current Gross Profit is estimated to increase to about (88.7 M). The current Pretax Profit Margin is estimated to decrease to -0.46. As of now, Denali Therapeutics' Non Current Assets Total are increasing as compared to previous years. The Denali Therapeutics' current Non Currrent Assets Other is estimated to increase to about 19.1 M, while Total Assets are projected to decrease to under 932.8 M.
  
It's important to approach Denali Therapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Denali Therapeutics price targets

Denali Therapeutics' stock target price is an estimate of its future price, usually made by analysts. Using Denali Therapeutics' target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Denali Therapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Denali Therapeutics' stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Denali Therapeutics Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Denali Therapeutics is a key component of Denali Therapeutics valuation and have some predictive power on the future returns of a Denali Therapeutics.
Hype
Prediction
LowEstimatedHigh
21.3524.7728.19
Details
Intrinsic
Valuation
LowRealHigh
22.2231.7035.12
Details
Naive
Forecast
LowNextHigh
16.8320.2523.68
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.73-0.69-0.65
Details

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Gambling Idea
Gambling
Invested over 90 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Investor Favorites Idea
Investor Favorites
Invested over 60 shares
Impulse Idea
Impulse
Invested over 100 shares
Banking Idea
Banking
Invested over 20 shares
Macroaxis Picks Idea
Macroaxis Picks
Invested over 40 shares
Disruptive Technologies Idea
Disruptive Technologies
Invested few shares
Blockchain Idea
Blockchain
Invested few shares
Driverless Cars Idea
Driverless Cars
Invested over 50 shares
Chemicals Idea
Chemicals
Invested over 30 shares
Manufacturing Idea
Manufacturing
Invested over 30 shares
Baby Boomer Prospects Idea
Baby Boomer Prospects
Invested over 60 shares
Hedge Favorites Idea
Hedge Favorites
Invested few shares
When determining whether Denali Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Denali Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Denali Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Denali Therapeutics Stock:
Check out Macroaxis Advice on Denali Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For more detail on how to invest in Denali Stock please use our How to Invest in Denali Therapeutics guide.
You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.